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Abstract Cocaine and amphetamine regulated transcript
(CART) is a newly discovered hypothalamic peptide with a
potent appetite suppressing activity following intracerebroven-
tricular administration. When the mature rat CART sequence
encoding CART(1^102) was inserted in the yeast expression
plasmid three CART peptides could be purified from the
fermentation broth reflecting processing at dibasic sequences.
None of these corresponded to the naturally occurring
CART(55^102). In order to obtain CART(55^102) the precursor
Glu-Glu-Ile-Asp-CART(55^102) has been produced and
CART(55^102) was generated by digestion of the precursor
with dipeptidylaminopeptidase-1. All four generated CART
peptides have been characterised by N-terminal amino acid
sequencing and mass spectrometry. The CART peptides contain
six cysteine residues and using the yeast expressed CART(62^
102) the disulphide bond configuration was found to be I^III, II^
V and IV^VI. When the four CART peptides were intracer-
ebroventricularly injected in fasted mice (0.1 to 2.0 Wg) they all
produced a dose dependent inhibition of food intake.
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1. Introduction
Cocaine and amphetamine regulated transcript (CART)
was originally described as an mRNA induced in the brain
after acute administration of cocaine to rats [1]. In the search
for the factor that induces anorexia in rats implanted with
certain tumour lines [2] we applied the method of subtraction
cloning/hybridisation. By subtracting cDNA from a non-ano-
rectic tumour cell line from that of an anorectic we found that
the mRNA for CART was highly overexpressed in the latter.
The CART cDNA encodes a peptide of either 129 or 116
amino acid residues in length [1]. The predicted leader se-
quence was 27 amino acid residues, thus resulting in a mature
CART peptide consisting of either 102 (long form) or 89
(short form) amino acid residues [1]. In contrast to the rat,
only the short form exists in humans [3]. The mature peptide
contains several potential cleavage sites (mono- and dibasic
sequences) and CART might be posttranslationally processed
in vivo into several biologically active fragments. Posttransla-
tional processing at a Lys-Arg sequence in the middle of the
molecule would generate an N-terminal CART(1^52) and a
C-terminal CART(55^102) fragment. The latter of these frag-
ments has actually been isolated from ovine hypothalamic
extracts [4] thus indicating that CART is processed at the
Lys-53-Arg-54 sequence at least in the ovine brain. In a recent
study several CART peptides have been shown to inhibit food
intake when injected ICV in rats [5].
Only limited amounts of CART can be isolated from brain
tissue [4], and due to the existence of three disulphide bonds in
the C-terminal part of the molecule the preparation of CART
by peptide synthesis is very di⁄cult. In the present study we
describe a yeast expression system suitable for the production
of relatively large amounts of CART peptides, including the
naturally occurring CART(55^102). The biological activity of
the recombinant CART peptides was determined in an acute
feeding assay after ICV injection, and we have elucidated the
disulphide bond con¢guration in the CART molecule using
recombinant CART(62^102).
2. Material and methods
2.1. General methods
Two di¡erent CART expression systems were constructed. In the
¢rst expression system the gene encoding the entire CART(1^102) was
inserted in the expression plasmid. Several di¡erent CART peptides
could be isolated after the fermentation of this construction, but none
of these was full length CART(1^102) or CART(55^102) (see Section
3).
In the other system the gene encoding a Glu-Glu-Ile-Asp-
CART(55^102) precursor was used. After fermentation the Glu-Glu-
Ile-Asp-CART(55^102) peptide could be isolated from the fermenta-
tion broth and converted to CART(55^102) by digestion with dipep-
tidylaminopeptidase-1 (DAP-1).
2.2. Cloning of CART and plasmid construction
In the search for the factor that induces anorexia in rats implanted
with certain tumour lines [2] we applied the method of subtraction
cloning/hybridisation using the Subtractor kit (Invitrogen, CA) with
minor modi¢cations. By subtracting cDNA from a non-anorectic tu-
mour cell line from that of an anorectic we found that the mRNA for
CART [1] was highly overexpressed in the latter. In order to obtain
the full length cDNA for CART we performed a PCR on the cDNA
from the anorectic cell line using primers overlapping the translation
start and stop sequences. For expression of either full length
CART(1^102) or Glu-Glu-Ile-Asp-CART(55^102) we constructed
the following plasmids for yeast expression using the K-leader se-
quence to facilitate secretion and the Kex2 endoprotease for matura-
tion.
Plasmid pEA183, encoding CART(1^102), was constructed as fol-
lows: The DNA encoding mature CART was furnished with a 5P
NcoI site and a 3P XbaI site allowing insertion into the yeast expres-
sion vector pAK405. The K-leader in pAK405 has been modi¢ed at
positions 63 and 64 from Lys-Asp to Met-Ala introducing an NcoI
site at this position in the DNA [6]. An expression vector encoding a
fusion between K-leader and CART was constructed as follows:
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Brie£y, a PCR reaction was performed on full length CART with
primer CART1: 5P-ACGGAGGAGCCCATGGCTAAGAGACAG-
GAGGATGCCGAGCTGCAGC-3P and primer CART2: 5P-
CTTAACGGCTTCTAGATCACAAGCACTTCAAGAGG-3P (letters
in bold denote CART sequence). The PCR fragment was digested
with NcoI and XbaI and ligated to the BstXI/XbaI and BstXI/NcoI
fragments of pAK405. The sequence of the DNA encoding CART
was con¢rmed using the dideoxy-chain termination method with the
Sequenase enzyme (Amersham). The resulting plasmid was named
pEA183.
Plasmid pSX637, encoding Glu-Glu-Ile-Asp-CART(55^102), was
constructed by the use of the PCR technique ‘Splicing by Overlap
Extension’ [7] and the product was inserted into pAK405 as men-
tioned above. The resulting expression plasmid is shown in Fig. 1.
As can be seen from this ¢gure a sequence of: Lys-Glu-Leu-Glu
have been placed between the K-leader and Kex2 site in order to
optimise processing [6].
2.3. Construction of CART secreting yeast strains
Plasmids pEA183 and pSX637 were transformed into Saccharomy-
ces cerevisiae strains ME1487 (MATK vyap3: :URA3 vtpi: :LEU2
pep4-3 vura3 leu2) and ME1719 (MATK/MATa vyap3: :URA3/
vyap3: :URA3 vtpi: :LEU2/vtpi: :LEU2 pep4-3/pep4-3 vura3/vura3
leu2/leu2), respectively. Host cells were cultured in YPGGE medium
(1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) galactose, 2%
(v/v) glycerol and 1% (v/v) ethanol) to OD600nm of 0.2. Transforma-
tion was made by using a standard protoplast method. Transform-
ants, YEA183 and YES1789, were obtained, which contained
CART(1^102) and EEID-CART expressing plasmids, respectively,
after transformants were selected on minimal plates containing glu-
cose.
2.4. Fermentations
Fermentations of CART(1^102) (yeast strain: ME1487) and EEID-
CART(55^102) (yeast strain: YES1789) were carried out in 6 l stain-
less steel fermenters from Chemap A/B, Schwitzerland, equipped with
bottom stirrer and in situ steam sterilisation. The medium was com-
posed essentially as previously described [8] and a starting volume of
4 l was chosen. Ammonia was added to adjust pH throughout the
fermentation to 4.9 and the temperature was kept constant at 30‡C
with steam/cooling water. Dissolved oxygen was kept above 50% sat-
uration by frequent adjustment of the stirrer speed. The inoculum was
from a YPD (yeast-extract peptone dextrose) culture (2 days, 30‡C).
Glucose (1250 g) was dissolved in water to a volume of 2 l, sterilised
separately in an autoclave (30 min, 121‡C), and added with a constant
rate of 30 g/h over the ¢rst 24 h. The rate was increased to 60 g/l over
the next 24 h. After 48 h of cultivation the broth was harvested.
The CART(1^102) broth was adjusted to pH 4.0 with 1 N HCl and
the cells separated by centrifugation in a Beckman J6 cooling centri-
fuge (at 4‡C, 15 min, 4000 rpm). The EEID-CART(55^102) broth was
adjusted to pH 11 with 3 N NaOH and kept at 25‡C for 30 min
before centrifugation as above. The supernatant was adjusted to pH
9.7 to protect against proteolyses before the puri¢cation was initiated.
The dry biomass in the two fermentations was: 70.4 g/l (CART(1^
102)) and 73.6 g/l (EEID-CART(55^102)), respectively. The weight of
the total fermentation broth was 5466 g and 5706 g, respectively.
2.5. Puri¢cations
The fermentation broth from yeast strain ME1487 encoding
CART(1^102) was analysed by HPLC (Fig. 2). A series of expression
products was seen in this analysis. Preliminary sequence analysis in-
dicated that several of the peptides eluting at a retention time between
20 and 30 min were fragments of the mature full length CART(1^102)
molecule.
The CART peptides from 4.25 l of fermentation supernatant were
separated and puri¢ed using the following method: The fermentation
broth (pH 4.6, 1 8 mS) was adjusted to pH 5.0 and diluted with 25 l
of water (resulting 1 1.3 mS) and pumped (500 ml/h) onto an SP-
Sepharose (Pharmacia) column (5U15 cm) previously equilibrated
with 50 mM HAc at pH 5.0. The column was eluted with a linear
gradient between 1500 ml of 50 mM HAc and 1500 ml of 50 mM HAc
containing 1.0 M NaCl. Fractions of 10 ml were collected and ana-
lysed for the content of CART peptides by HPLC. The chromato-
gram from the ion exchange chromatography is shown in Fig. 3.
Three pools (A, B and C) were generated on the basis of the HPLC
analysis of the individual fractions and CART peptides corresponding
to these pools were puri¢ed by preparative HPLC on a Vydac
214TP1022 reverse phase C4 preparative HPLC column (2.2U25
cm) as previously described [8]. The total yields of CART peptides
from 4.25 l of fermentation supernatant were: peptide A: 33 mg,
peptide B: 200 mg and peptide C: 280 mg.
The fermentation supernatant (4.6 l) from yeast strain YES1789
expressing Glu-Glu-Ile-Asp-CART(55^102) was dialysed against 60 l
of water at 4‡C for 96 h. The pH was adjusted to 4.3 and the solution
was pumped onto an SP-Sepharose (Pharmacia) column (5U15 cm)
with a £ow rate of 300 ml/h. Prior to the application the column was
equilibrated with 50 mM HAc bu¡er pH 4.25. The column was
washed with 3 l of 50 mM HAc bu¡er pH 4.25. EEID-CART(55^
102) was eluted from the column by a linear gradient between 1.5 l of
50 mM HAc bu¡er pH 4.25 and 1.5 l of 50 mM HAc bu¡er pH 4.25
containing 1 M NaCl. Fractions (10 ml) were collected at a £ow rate
of 100 ml/h and the absorbance was measured at 280 nm. The EEID-
CART(55^102) molecule eluted at 0.5 M of NaCl and fractions con-
taining the peptide were dialysed against 25 l of 50 mM HAc bu¡er
pH 4.5 at 4‡C for 96 h. L-cysteine was added to the solution (560 ml)
to give a ¢nal concentration of 1 mM, and 4.5 ml dipeptidylamino-
peptidase-1 (DAP-1, Cathepsin C from chicken liver, EC 3.4.14.1,
Unizyme Laboratories) was added. The resulting concentration of
DAP-1 was 20 units/ml. The digestion of EEID-CART(55^102) was
carried out at 37‡C and aliquots were analysed by HPLC each half
hour. After incubation for 4.5 h more than 98% of the precursor was
converted to CART(55^102). The CART(55^102) peptide was puri¢ed
essential as fragments A, B and C described above. The total yield of
CART(55^102) from 4.6 l of fermentation supernatant was 705 mg.
2.6. Characterisation of CART peptides
The isolated CART peptides all gave rise to a single peak when
analysed by HPLC (results not shown).
N-terminal amino acid sequences were determined by automated
Edman degradations using an Applied Biosystem Model 494 Protein
Sequencer essentially as described by the manufacturer.
Mass spectrometric analysis was performed on a Voyager RP
MALDI-TOF instrument (Perceptive Biosystems Inc., Framingham,
MA) equipped with a nitrogen laser (337 nm). The instrument was
operated in linear mode with delayed extraction, and the accelerating
voltage in the ion source was 25 kV.
Sample preparation was done as follows: 1 Wl sample solution was
mixed with 10 Wl matrix solution (alpha-cyano-4-hydroxy-cinnamic
acid dissolved in a 5:4:1 (v/v/v) mixture of acetonitrile:water:3% (v/
v) TFA) and 1 Wl was deposited on the sample plate and allowed to
dry. Calibration was performed using external standards and the ac-
curacy of the mass determinations is within 0.1%.
2.7. Disulphide bond con¢guration in CART
The mature CART(1^102) molecule contains six cysteine residues in
the C-terminal part of the molecule in positions 68, 74, 86, 88, 94 and
101. These six cysteine residues can in principle form three disulphide
bonds in 15 di¡erent arrangements [9]. The following procedure was
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Table 1
N-terminal sequence and mass spectrometry analyses of isolated CART peptides
Peptide N-terminal sequence Mass found Mass calculated
CART(54^102) RIPIYEKKYGT 5418.0 5415.4
CART(61^102) KYGQVPMXDAT 4516.5 4515.3
CART(62^102) YGQVPMXDAGT 4389.9 4387.1
CART(55^102) IPIYEKKYGQT 5257.1 5255.5
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used for the disulphide mapping: CART(62^102), 1 mg, was dissolved
in 300 Wl of 50 mM N-ethylmorpholine bu¡er at pH 8.0. Five nmole
Armillaria mellea protease, an enzyme cleaving on the N-terminal side
of lysine residues [10], was dissolved in 50 Wl of 50 mM N-ethylmor-
pholine bu¡er at pH 8.0 and was added to the solution. The digestion
was carried out for 17 h. A further 10 nmole of Armillaria mellea
protease was added and the digestion continued for an additional 5
h. Peptide mapping was carried out by injection of the digest mixture
onto a Vydac 214TP54 column (4.6U250 mm) equilibrated at 30‡C at
a £ow rate of 1 ml/min with 0.1% (v/v) TFA. The concentration of
acetonitrile in the eluting solvent was raised to 40% (v/v) over 40 min.
From the sequence and mass spectrometry analysis the structure of
the peptides representing the main peaks of the chromatogram (Fig.
4) were deduced as follows:
Fraction 3 (Fig. 4): Lys-Gly-Ala-Arg-Ile-Gly. Fractions 4 and 5
(Fig. 4): Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-
Ala-Val-Arg, Lys-Leu-Cys-Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-
Ser-Phe-Leu-Leu and Lys-Cys-Leu. Fractions 6 and 7 (Fig. 4): undi-
gested CART(62^102).
The ¢rst of these fragments is a small hexapeptide without any
cysteine residues. The fragment isolated from fractions 4 and 5 is a
3-chained molecule still held together by the three disulphide bonds.
The reason for the existence of this peptide at two di¡erent HPLC
positions is the presence of a methionine residue, which appears in an
oxidised and a non-oxidised form.
The 3-chained CART(62^77, 84^99, 100^102), 100 Wg, was dis-
solved in 300 Wl of 50 mM phosphate bu¡er at pH 8.0 and digested
with 2 Wg Endoproteinase Asp-N (Boehringer, Cat. No. 1054 589).
The incubation was carried out at 37‡C for 24 h. The resulting peptide
map is shown in Fig. 5. From the sequence and mass spectrometry
analyses the structure of the peptides representing the main peaks of
the chromatogram were deduced as follows:
Fractions 3 and 4 (Fig. 5): Tyr-Gly-Gln-Val-Pro-Met-Cys and Lys-
Leu-Cys. Fraction 5 (Fig. 5): Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg,
Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu and Lys-
Cys-Leu.
The fragments isolated from fractions 3 and 4 represent a 2-chained
molecule held together by a single disulphide bond. Thus cysteine
residues I and III of the original molecule must be linked. The frag-
ments isolated from fraction 5, which contain cysteine residues II, IV,
V and VI of the original molecule in a 3-chained structure linked by
two disulphide bonds, was further digested with trypsin. The follow-
ing procedure was used: 10 Wg of CART(69^77, 87^99, 100^102) was
dissolved in 275 Wl of 0.1 M Tris-HCl bu¡er at pH 8.5 and digested by
2 Wg trypsin (Boehringer, Cat. No. 1047 841) dissolved in 20 Wl of
0.01% (v/v) TFA at 37‡C for 4.5 h. The peptide map is shown in Fig.
6 and the structure of the peptides representing the main peaks of the
chromatogram were deduced as follows: Fraction 1 (Fig. 6): Asp-
Cys-Pro-Arg and Lys-Cys-Leu. Fraction 2 (Fig. 6): Asp-Ala-Gly-
Glu-Gln-Cys and Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu. Fraction 3
(Fig. 6): Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg and Gly-Thr-Ser-
Cys-Asn-Ser-Phe-Leu-Leu.
From the above results it is clear that Cys-II and Cys-V are linked
(fractions 2 and 3) and that Cys-IV and Cys-VI are linked (fraction 1).
By combining all of the above results the entire primary and sec-
ondary structure of the C-terminal part of the CART molecule can be
deduced. Thus the disulphide bond in the C-terminal part of the
CART molecule exists in a I^III, II^V and IV^VI con¢guration
(Fig. 7).
2.8. Biological activity of recombinant CART peptides
The appetite suppression activity of the puri¢ed CART peptides
was analysed using the following methods: Female NMRI mice
were fasted for 24 h after exposure to the test diet, a nutritionally
complete formula milk. Thirty minutes before testing, 10 Wl of a
solution containing CART peptide or vehicle (phosphate bu¡ered
saline) was injected ICV in the lateral ventricle. Each mouse was
placed in a 15 cm2 test box with a grid £oor and a glass drinking
tube containing the formula milk. Food consumption was measured
for 10 min by electronically recording the total amount of contact
with the milk during the test session. The degree of appetite suppres-
sion produced by a dose of peptide was evaluated by comparing the
duration of consumption by control mice with that of treated mice.
Each group’s feeding response is expressed as percent relative to the
control response (100%).
3. Results
3.1. Expression and puri¢cation
The expression level for recombinant CART(1^102) and
Glu-Glu-Ile-Asp-CART(55^102) in the present yeast system
were approximately 200 mg/l and 250 mg/l, respectively.
This is a factor 2^3 times higher than we have previously
found for other small disulphide linked peptides [8,11].
When the full length CART(1^102) sequence was inserted in
the expression plasmid several CART peptides could be iso-
lated from the fermentation broth (Fig. 2). The dominating
fragments were: CART(54^102), CART(61^102) and
CART(62^102) which were separated and puri¢ed individu-
ally from the fermentation broth (Fig. 3). The fermentation
broth also contained other fragments e.g. CART(49^102), but
these were minor components and were not further puri¢ed
and characterised in the present study. The above peptides all
represent fragments generated by processing either between or
after dibasic sequences in the CART(1^102) by the action of
yeast proteases.
Since the naturally occurring CART(55^102) could not be
isolated from the above construction we modi¢ed the expres-
sion plasmid to encode Glu-Glu-Ile-Asp-CART(55^102) in-
stead of the full length CART(1^102). The extensive process-
ing at dibasic sequences observed for the full length
construction was not seen for this precursor, and only the
Glu-Glu-Ile-Asp-CART(55^102) peptide could be isolated
from the fermentation broth. The subsequent in vitro diges-
tion of the Glu-Glu-Ile-Asp-CART(55^102) peptide to
CART(55^102) using dipeptidylaminopeptidase-1 was carried
out with a yield close to 100%. The process was favoured by
the presence of a proline residue at position 2 of the
CART(55^102) peptide, blocking the DAP-1 enzyme from
further processing.
The overall puri¢cation yields from both fermentations
were approximately 60%, and the loss was mainly due to
the complex medium in which the yeast cells were grown.
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Fig. 1. S. cerevisiae plasmid for the expression and secretion of
Glu-Glu-Ile-Asp-CART(55^102). TPI-prom. and TPI-term. are S.
cerevisiae triosephosphate isomerase transcription promotor and ter-
minator sequences, respectively. TPI S. pombe is the Schizosacchar-
myces pombe triosephosphate isomerase gene. Only restriction sites
relevant for the plasmid construction have been indicated.
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3.2. Structural characterisation of CART peptides
The analytical HPLC chromatograms obtained on the pu-
ri¢ed CART peptides showed that all four peptides eluted
with nearly the same retention time. Based on N-terminal
sequence analysis of the individual peptides the purity was
determined to more than 98%. The four peptides were sub-
jected to amino acid sequence and mass spectrometry analyses
(Table 1). By combining these data the structure of the iso-
lated CART fragments were deduced to be: CART(54^102),
CART(61^102), CART(62^102) and the naturally occurring
CART(55^102). In all cases the molecular weight determined
by mass spectrometry analyses was within 3 mass units from
the theoretically calculated mass. These results also show that
no posttranslational modi¢cations (e.g. O-glycosylation) exist
in the recombinant peptides.
In order to simplify the elucidation of the disulphide con-
¢guration in the CART molecule the shortest of the isolated
CART peptides, CART(62^102), was used for these studies.
The strategy was to digest CART(62^102) by several speci¢c
proteases, using non-reducing conditions, until peptide frag-
ments containing a single disulphide bond were obtained. Us-
ing this strategy three peptides: CART(62^68, 84^86),
CART(87^90, 100^102) and CART(69^74, 91^99), all con-
taining a single disulphide bond, were isolated and their struc-
ture determined by mass spectrometry and sequence analyses.
By combining these data the cysteines, when numbered from
the N-terminal end, are linked in the con¢guration: I^III, II^
V and IV^VI. This con¢guration was determined for the
CART(62^102) peptide, but it seems highly probable that
the same disulphide bond con¢guration exists in the other
CART peptides as well as in naturally occurring CART,
although this has not been directly shown in the present
study.
Fig. 7 shows the I^III, II^V and IV^VI disulphide bond
con¢guration in CART(55^102).
3.3. Biological activity of recombinant CART peptides
Fig. 8 shows the inhibitory e¡ects on feeding of the four
isolated CART peptides.
The most active of these peptides was the naturally occur-
ring CART(55^102). The minimum e¡ective dose of this pep-
tide was between 0.1 Wg and 0.2 Wg, which inhibited food
intake by approximately 50%. However also the longer
form, CART(54^102) and the two shorter forms, CART(61^
102) and CART(62^102) were biologically active although a
somewhat higher dose was necessary to produce a 50% inhib-
ition of food intake.
4. Discussion
In the present study we describe the use of a yeast expres-
sion system for the production of mg to g amounts of CART
peptides. The expression levels in this system are relatively
high (200^250 mg/l) and the puri¢cation was straight forward,
resulting in an overall yield of approximately 60%. Further-
more the puri¢ed peptides are not posttranslationally modi-
¢ed. However, a drawback using this system was the extensive
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Fig. 4. Peptide map of AMP digested CART(62^102). Fractions
corresponding to the individual absorbance peaks were collected as
indicated. Peptide material in fractions 4 and 5 corresponding to the
3-chained CART(62^77, 84^99, 100^102) was further digested with
Asp-N protease (Fig. 5).
Fig. 3. Ion exchange chromatography on a Fast Flow SP-Sepharose
column of partially puri¢ed CART peptides. The amount of CART
peptide was determined by analytical HPLC. The bars indicate the
fractions pooled for further puri¢cation. The dashed line shows the
concentration of NaCl in the eluting solvent.Fig. 2. Reversed phase HPLC on a Vydac 214TP54 C4 column of
supernatants from yeast strain ME1487 expressing CART(1^102).
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processing at dibasic sequences observed when expression of
the full length CART(1^102) was attempted. In the present
yeast expression system it was necessary to construct a plas-
mid encoding the Glu-Glu-Ile-Asp-CART(55^102) precursor,
to purify this precursor, and to digest it to CART(55^102) to
obtain the naturally occurring form of CART. The use of this
precursor did not result in any processing e.g. at the dibasic
sequence Lys-60-Lys-61 where extensive processing was seen
for the full length precursor. One possible explanation for this
could be that the Lys-60-Lys-61 sequence in the Glu-Glu-Ile-
Asp-CART(55^102) precursor is less exposed to proteolytic
cleavage than the corresponding sequence in the full length
precursor.
The digestion of the Glu-Glu-Ile-Asp-CART(55^102) pre-
cursor with dipeptidylaminopeptidase-1 was very e⁄cient and
resulted in a close to 100% yield. This high yield was probably
due to the presence of a proline residue in position 2 of the
CART(55^102) molecule, which totally blocks the dipeptidyl-
aminopeptidase-1 from attacking this molecule. A similar spe-
ci¢city of dipeptidylaminopeptidase-1 has previously been re-
ported for other peptide substrates as well [12].
Apart from the study by Spiess et al. in 1981 [4], in which
they identi¢ed the CART(55^102) peptide in ovine hypotha-
lamic extracts, no studies have so far been carried out to
determine the form of naturally occurring CART. Using a
polyclonal antiserum directed against CART(28^56) Smith
and co-workers [13] have localised CART immunoreactivity
in the nucleus accumbens of monkey brains. This area of the
brain constitute the major part of the ventral striatum, which
is thought to be involved in a variety of functions, including
regulation of motor and motivational behaviours as well as
drug reinforcement [14,15].
Due to the presence of several mono- and dibasic sequences
in CART(1^102) (or the corresponding human CART(1^89))
molecule, it seems likely that posttranslational processing oc-
curs in vivo, thus generating several biologically active pep-
tides. In the present study we have focused on the naturally
occurring CART(55^102) molecule, but apparently also the
shorter peptides CART(60^102) and CART(61^102) as well
as the longer CART(54^102) are biologically active (Fig. 8),
and the potency of these peptides is almost as high as for
CART(55^102). These results seem to indicate that the C-ter-
minal part of the CART molecule containing the three disul-
phide bridges is important for biological activity.
As a ¢rst step in elucidation of the 3-dimensional structure
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Fig. 7. Proposed structure of the naturally occurring CART(55^102)
showing the disulphide bond con¢gurations I^III, II^V, IV^VI.
Fig. 6. Tryptic map of CART(69^77, 87^99, 100^102). Fraction 1
corresponded to the 2-chained CART(87^90, 100^102) and fraction
2 to the 2-chained CART(69^74, 91^99).
Fig. 5. Peptide map of Asp-N protease digested CART(62^77, 84^
99, 100^102). The peptide eluting in fraction 3 corresponded to the
2-chained CART(62^68, 84^86). The peptide eluting in fraction 5
corresponded to the 3-chained CART(69^77, 87^99, 100^102), and
was further digested with trypsin (Fig. 6).
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of the C-terminal part of CART we have determined the
disulphide bond con¢guration. Six cysteine residues can in
principle form disulphide bonds in 5U3U1 = 15 possible
ways, and all of these 15 combinations actually exist in natu-
rally occurring peptides and proteins [9]. The I^III, II^V, IV^
VI arrangements found in CART (Fig. 7) have so far only
been found in rabbit Ig kappa chains [9]. However no other
similarities (e.g. sequence homology) exist between this pro-
tein and CART. Thus, the C-terminal part of the CART
molecule containing the three disulphide bonds seems to
form a new domain not found in any other peptides or pro-
teins.
In summary, the yeast expression system described in the
present study may be a valuable tool for generation of mg to g
amounts of CART peptides for further biological and phys-
iological studies of this new peptide family.
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Fig. 8. Biological activity of the isolated CART peptides. The ¢gure
shows the dose dependent inhibitory e¡ects on feeding of the four
isolated CART peptides. The ¢gure shows the food consumption
þ S.E.M. in percent of control (100%). Each data point represents a
group of six animals.
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